Hôpital Riviera-Chablais (Vaud-Valais), service des urgences
Rennaz, Canton of Vaud, 1847, Switzerland
NCT Number: NCT07282379
The healthcare systems are under increasing pressure due to a rise in emergency consultations, staff shortages, an ageing population and rising costs. Emergency departments are seeing more vulnerable patients, including elderly people, who are often on multiple medications and at risk of medication errors.
To improve safety, the integration of pharmacists specialising in emergency medicine has proven beneficial: their presence in the team improves the detection of medication-related problems, speeds up and optimises treatment, reduces rehospitalisations and lowers healthcare costs. However, in most countries, these pharmacists are still rarely found in emergency departments, mainly due to a lack of resources and clinical prioritisation criteria tailored for them and adapted to this environment.
Frailty screening tools and scores, such as ISAR, can be used to identify the elderly patients most at risk, predict adverse events such as fall or mortality, and thus adapt their care in the emergency department. Indeed, elderly frail patients often take many medications and consequently are at risk of medication errors, adverse events, inappropriate prescriptions or serious drug interactions. These patients may therefore require a specialised review on their medication by clinical pharmacists when they are admitted to the emergency department, but their high number make it impossible to care for all of them.
We aim thus to evaluate the association between frailty (according to the ISAR score) and medication-related problems among elderly patients admitted to the emergency department. Researchers will examine whether this score can predict the presence of inappropriate prescribing and high-risk drug interactions. If so, pharmacists would then have a quick and easy tool to prioritise patients who would benefit most from a specialised review of their medications when they visit the emergency department.
There will not be any intervention and this study will not influence patients care. Once patients agree to participate, researchers will prospectively collect medical data from elderly patients admitted to the emergency department and analyse their medical history, home medication, reason for admission, frailty score using ISAR, and perform a pharmaceutical analysis based on these data.
Trial opening soon.
Get Notified75 year and older
All sexes
Observational
Rennaz, Canton of Vaud, 1847, Switzerland
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
After inclusion, each patient's data will be collected and analysed by the investigator in the following 5 days. The said data will be:
Time frame: At the time of their admission to the emergency department
The rate of inappropriate prescription (PIP) will be compared as a function of their ISAR score, using Poisson regression analysis. PIPs will be defined according to the STOPP/START online tool version 3, developed for geriatric patients.
Time frame: At the time of their admission to the emergency department
The rate of high-risk drug-drug interactions (DDIs) will be compared as a function of their ISAR score, using Poisson regression analysis. High-risk DDIs will be detected with the Lexicomp™ Interact online tool and only categories D ("Consider therapy modification") and X ("Avoid combination") will be considered.
Time frame: At the time of their admission to the emergency department.
Determining optimal ISAR threshold for predicting medication problems further improves its use in clinical settings. If possible, sensitivity, specificity, positive predictive value, negative predictive value, and Youden index will be calculated.
Time frame: At the time of their admission to the emergency department.
After pharmaceutical analysis of the electronic patient file, DRPs will be classified according to the Pharmaceutical Care Network Europe Association (PCNE) V9.
Time frame: At the time of their admission to the emergency department.
The likelihood of a medication-related emergency visit will be measured with the AT-HARM 10 score. This score gives a binary result ("possibly" or "unlikely" medication-related visit) and is a useful tool to exclude patients who are unlikely to be admitted due to a medication issue.
Contact information is provided by the study sponsor or research team.
Pharmacie des Hopitaux de l'Est Lemanique
Other
DETECTION OF ISAR-FLAGGED AT-RISK MEDICATION IN THE EMERGENCY DEPARTMENT (DISARMED)
Acronym: DISARMED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07259499
Alzheimer s Disease, Arterial Occlusive Diseases
Pisa, Italy
View Trial DetailsNCT06869148
Disease Attributes, Emergencies
Linköping, Östergötland County, Sweden
View Trial DetailsNCT04692233
Cancer, Elderly
Hong Kong
View Trial DetailsNCT04615065
Acute Disease, Acute Kidney Injury
Groningen, Netherlands
View Trial Details